,Condition,Recommendation,Rationale,ExStandardized
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",CILOSTAZOL
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",ACETYLSALICYLIC ACID
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",DICLOFENAC
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",DIFLUNISAL
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",ETODOLAC
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",FENOPROFEN
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",IBUPROFEN
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",KETOPROFEN
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",MECLOFENAMIC ACID
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",MEFENAMIC ACID
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",MELOXICAM
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",NABUMETONE
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",NAPROXEN
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",OXAPROZIN
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",PIROXICAM
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",SULINDAC
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",TOLMETIN
0,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",CELECOXIB
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",CILOSTAZOL
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",DILTIAZEM
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",VERAPAMIL
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",ACETYLSALICYLIC ACID
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",DICLOFENAC
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",DIFLUNISAL
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",ETODOLAC
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",FENOPROFEN
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",IBUPROFEN
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",KETOPROFEN
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",MECLOFENAMIC ACID
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",MEFENAMIC ACID
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",MELOXICAM
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",NABUMETONE
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",NAPROXEN
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",OXAPROZIN
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",PIROXICAM
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",SULINDAC
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",TOLMETIN
0,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",CELECOXIB
0,"Heart failure with reduced ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,PIOGLITAZONE
0,"Heart failure with reduced ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,ROSIGLITAZONE
0,"Heart failure with reduced ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,DRONEDARONE
0,"Heart failure with preserved ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,PIOGLITAZONE
0,"Heart failure with preserved ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,ROSIGLITAZONE
0,"Heart failure with preserved ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,DRONEDARONE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,DONEPEZIL
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,RIVASTIGMINE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,GALANTAMINE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,TACRINE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,DOXAZOSIN
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,PRAZOSIN
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,TERAZOSIN
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,AMITRIPTYLINE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,IMIPRAMINE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,CLOMIPRAMINE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,TRIMIPRAMINE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,DOXEPIN
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,CHLORPROMAZINE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,THIORIDAZINE
0,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,OLANZAPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DISOPYRAMIDE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",MEPYRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIPROLIDINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",AMITRIPTYLINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",AMOXAPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLOMIPRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DESIPRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DOXEPIN
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DARIFENACIN
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",IMIPRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",FESOTERODINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",NORTRIPTYLINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",FLAVOXATE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PAROXETINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",OXYBUTYNIN
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROTRIPTYLINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",SOLIFENACIN
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIMIPRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TOLTERODINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TROSPIUM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROCHLORPERAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROMETHAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",BENZATROPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIHEXYPHENIDYL
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",BROMPHENIRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CARBINOXAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORPROMAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORPHENIRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLOZAPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLEMASTINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CYPROHEPTADINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",OLANZAPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DEXBROMPHENIRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORPHENIRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",THIORIDAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DIMENHYDRINATE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIFLUOPERAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DIPHENHYDRAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DOXYLAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HYDROXYZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ATROPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",MECLIZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",METHYLSCOPOLAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DICYCLOMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HOMATROPINE METHYLBROMIDE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HYOSCYAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CYCLOBENZAPRINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",METHYLSCOPOLAMINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ORPHENADRINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROPANTHELINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ALPRAZOLAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ESTAZOLAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",LORAZEPAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",OXAZEPAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TEMAZEPAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIAZOLAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORDIAZEPOXIDE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLONAZEPAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLORAZEPATE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DIAZEPAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",FLURAZEPAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",QUAZEPAM
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORPROMAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DROPERIDOL
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",FLUPHENAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HALOPERIDOL
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",LOXAPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PERPHENAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PIMOZIDE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROCHLORPERAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",THIORIDAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",THIOTHIXENE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIFLUOPERAZINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ARIPIPRAZOLE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ASENAPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLOZAPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ILOPERIDONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",LURASIDONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",OLANZAPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PALIPERIDONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",QUETIAPINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",RISPERIDONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ZIPRASIDONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HYDROCORTISONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HYDROCORTISONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",BETAMETHASONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PREDNISONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PREDNISOLONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIAMCINOLONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",METHYLPREDNISOLONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DEXAMETHASONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CIMETIDINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",FAMOTIDINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",NIZATIDINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",RANITIDINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",MEPERIDINE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ESZOPICLONE
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ZALEPLON
0,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ZOLPIDEM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DISOPYRAMIDE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",MEPYRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIPROLIDINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",AMITRIPTYLINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",AMOXAPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLOMIPRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DESIPRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DOXEPIN
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DARIFENACIN
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",IMIPRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",FESOTERODINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",NORTRIPTYLINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",FLAVOXATE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PAROXETINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",OXYBUTYNIN
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROTRIPTYLINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",SOLIFENACIN
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIMIPRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TOLTERODINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TROSPIUM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROCHLORPERAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROMETHAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",BENZATROPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIHEXYPHENIDYL
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",BROMPHENIRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CARBINOXAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORPROMAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORPHENIRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLOZAPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLEMASTINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CYPROHEPTADINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",OLANZAPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DEXBROMPHENIRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORPHENIRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",THIORIDAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DIMENHYDRINATE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIFLUOPERAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DIPHENHYDRAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DOXYLAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HYDROXYZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ATROPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",MECLIZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",METHYLSCOPOLAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DICYCLOMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HOMATROPINE METHYLBROMIDE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HYOSCYAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CYCLOBENZAPRINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",METHYLSCOPOLAMINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ORPHENADRINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROPANTHELINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ALPRAZOLAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ESTAZOLAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",LORAZEPAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",OXAZEPAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TEMAZEPAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIAZOLAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORDIAZEPOXIDE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLONAZEPAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLORAZEPATE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DIAZEPAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",FLURAZEPAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",QUAZEPAM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ESZOPICLONE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ZALEPLON
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ZOLPIDEM
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CHLORPROMAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",DROPERIDOL
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",FLUPHENAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",HALOPERIDOL
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",LOXAPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PERPHENAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PIMOZIDE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PROCHLORPERAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",THIORIDAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",THIOTHIXENE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",TRIFLUOPERAZINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ARIPIPRAZOLE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ASENAPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",CLOZAPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ILOPERIDONE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",LURASIDONE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",OLANZAPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",PALIPERIDONE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",QUETIAPINE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",RISPERIDONE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",ZIPRASIDONE
0,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PHENYTOIN
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",VALPROIC ACID
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PHENOBARBITAL
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",LAMOTRIGINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CARBAMAZEPINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",TOPIRAMATE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",OXCARBAZEPINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ZONISAMIDE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",GABAPENTIN
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",LEVETIRACETAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PREGABALIN
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CLONAZEPAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",LACOSAMIDE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",RUFINAMIDE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",VIGABATRIN
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CHLORPROMAZINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",DROPERIDOL
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",FLUPHENAZINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",HALOPERIDOL
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",LOXAPINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PERPHENAZINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PIMOZIDE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PROCHLORPERAZINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",THIORIDAZINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",THIOTHIXENE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",TRIFLUOPERAZINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ARIPIPRAZOLE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ASENAPINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CLOZAPINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ILOPERIDONE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",LURASIDONE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",OLANZAPINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PALIPERIDONE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",QUETIAPINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",RISPERIDONE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ZIPRASIDONE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ALPRAZOLAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ESTAZOLAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",LORAZEPAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",OXAZEPAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",TEMAZEPAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",TRIAZOLAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CHLORDIAZEPOXIDE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CLONAZEPAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CLORAZEPATE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",DIAZEPAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",FLURAZEPAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",QUAZEPAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ESZOPICLONE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ZALEPLON
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ZOLPIDEM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",AMITRIPTYLINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",AMOXAPINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CLOMIPRAMINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",DESIPRAMINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",DOXEPIN
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",IMIPRAMINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",NORTRIPTYLINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PAROXETINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PROTRIPTYLINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",TRIMIPRAMINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CITALOPRAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",ESCITALOPRAM
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",FLUOXETINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",PAROXETINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",SERTRALINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",DESVENLAFAXINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",DULOXETINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CHLORAMPHENICOL
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",MILNACIPRAN
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",VENLAFAXINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CHLORDIAZEPOXIDE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",HEROIN
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",CODEINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",OXYCODONE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",HYDROCODONE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",TRAMADOL
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",MORPHINE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",HYDROMORPHONE
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",FENTANYL
0,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",DOXAZOSIN
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",METOCLOPRAMIDE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",PROCHLORPERAZINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",PROMETHAZINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",CHLORPROMAZINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",DROPERIDOL
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",FLUPHENAZINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",HALOPERIDOL
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",LOXAPINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",PERPHENAZINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",PIMOZIDE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",PROCHLORPERAZINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",THIORIDAZINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",THIOTHIXENE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",TRIFLUOPERAZINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",ARIPIPRAZOLE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",ASENAPINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",ILOPERIDONE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",LURASIDONE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",OLANZAPINE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",PALIPERIDONE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",RISPERIDONE
0,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",ZIPRASIDONE
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,ACETYLSALICYLIC ACID
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,DICLOFENAC
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,DIFLUNISAL
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,ETODOLAC
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,FENOPROFEN
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,IBUPROFEN
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,KETOPROFEN
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,MECLOFENAMIC ACID
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,MEFENAMIC ACID
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,MELOXICAM
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,NABUMETONE
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,NAPROXEN
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,OXAPROZIN
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,PIROXICAM
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,SULINDAC
0,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,TOLMETIN
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,ACETYLSALICYLIC ACID
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,DICLOFENAC
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,DIFLUNISAL
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,ETODOLAC
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,FENOPROFEN
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,IBUPROFEN
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,KETOPROFEN
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,MECLOFENAMIC ACID
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,MEFENAMIC ACID
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,MELOXICAM
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,NABUMETONE
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,NAPROXEN
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,OXAPROZIN
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,PIROXICAM
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,SULINDAC
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,TOLMETIN
0,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function,CELECOXIB
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),ESTRADIOL
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),ESTRADIOL
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),ESTRADIOL
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),OSPEMIFENE
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),ESTRADIOL
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),CONJUGATED ESTROGENS
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),ESTRONE
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),CONJUGATED ESTROGENS
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),ESTRADIOL
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),DOXAZOSIN
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),PRAZOSIN
0,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),TERAZOSIN
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,DISOPYRAMIDE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,MEPYRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,TRIPROLIDINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,AMITRIPTYLINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,AMOXAPINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,CLOMIPRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,DESIPRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,DOXEPIN
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,DARIFENACIN
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,IMIPRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,FESOTERODINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,NORTRIPTYLINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,FLAVOXATE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,PAROXETINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,OXYBUTYNIN
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,PROTRIPTYLINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,SOLIFENACIN
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,TRIMIPRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,TOLTERODINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,TROSPIUM
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,PROCHLORPERAZINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,PROMETHAZINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,BENZATROPINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,TRIHEXYPHENIDYL
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,BROMPHENIRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,CARBINOXAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,CHLORPROMAZINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,CHLORPHENIRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,CLOZAPINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,CLEMASTINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,CYPROHEPTADINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,OLANZAPINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,DEXBROMPHENIRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,CHLORPHENIRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,THIORIDAZINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,DIMENHYDRINATE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,TRIFLUOPERAZINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,DIPHENHYDRAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,DOXYLAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,HYDROXYZINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,ATROPINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,MECLIZINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,METHYLSCOPOLAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,DICYCLOMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,HOMATROPINE METHYLBROMIDE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,HYOSCYAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,CYCLOBENZAPRINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,METHYLSCOPOLAMINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,ORPHENADRINE
0,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,PROPANTHELINE
